Preeclampsia Subtypes and Surrogate Markers of CVD Risk

• Conditions: Preeclampsia

• Registration Number: NCT02337049
• Lead Sponsor: University of Aarhus

Brief Summary

In order to assess surrogate markers of cardiovascular risk in subtypes of preeclampsia, we will conduct a 10-year follow-up study comparing 40 women with a history of early onset preeclampsia; 40 women with a history of late onset preeclampsia and 40 women with a history of normotensive pregnancies.

Eligible participants delivered at the Department of Obstetrics at Randers Regional Hospital 1998-2008.

Early-onset preeclampsia is defined as preeclampsia that develops before 34 weeks of gestation, whereas late-onset preeclampsia develops at or after 34 weeks of gestation.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-09
• Status Verified: 2015-01
• Study First Submitted: 2015-01-05
• Study First Submitted QC: 2015-01-08
• Last Update Submitted: 2015-01-08
• Study First Posted: 2015-01-13
• Last Update Posted: 2015-01-13
• Primary Completion: 2015-12
• Study Completion: 2016-04

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

• Women who delievered at the Department of Obstetrics at Randers Regional Hospital 1998-2008

Read More

Exclusion Criteria

• Current pregnancy or breastfeeding

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Echocardiographic Markers of Cardiac Strain	10 years postpartum

Secondary Outcome Measures

Name	Time	Method
Circulating biomarkers of cardiovascular disease.	10 years postpartum
Markers of arteriosclerosis and atherosclerosis	10 years postpartum

Trial Locations

Locations (1)

Randers Regional Hospital; 🇩🇰 Randers, Randers NØ, Denmark